Praava Health, a network of family health centres in Dhaka, has opened molecular cancer diagnostics laboratory in Bangladesh. Praava will soon offer immunohistochemistry services and expanded cancer risk panels to provide more nuanced cancer diagnoses. Data on the cancer burden in Bangladesh are unreliable and sparse. It is estimated that there were more than 100,000 cancer deaths in 2018 — accounting for 10% of all deaths in the country. New cases are predicted to rise from 150,781 cases in 2018 to 250,726 cases in 2035.